Boston Research & Management’s iShares Russell 1000 Growth ETF IWF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$274K Hold
2,572
0.07% 98
2025
Q4
$304K Hold
2,572
0.07% 100
2025
Q3
$301K Hold
2,572
0.07% 102
2025
Q2
$273K Sell
2,572
-316
-11% -$30.2K 0.07% 101
2025
Q1
$260K Sell
2,888
-200
-6% -$19.7K 0.06% 102
2024
Q4
$310K Hold
3,088
0.08% 99
2024
Q3
$289K Hold
3,088
0.07% 104
2024
Q2
$281K Hold
3,088
0.07% 104
2024
Q1
$260K Sell
3,088
-156
-5% -$12.6K 0.06% 107
2023
Q4
$245K Hold
3,244
0.07% 107
2023
Q3
$215K Hold
3,244
0.06% 108
2023
Q2
$223K Buy
+3,244
New +$206K 0.06% 108
2022
Q2
Sell
-3,040
Closed -$210K 110
2022
Q1
$210K Hold
3,040
0.06% 106
2021
Q4
$232K Hold
3,040
0.06% 107
2021
Q3
$208K Hold
3,040
0.06% 106
2021
Q2
$206K Buy
+3,040
New +$196K 0.06% 106

Other funds holding IWF

Boston Research & Management's IWF Position: Q1 2026 in Review

Boston Research & Management held its iShares Russell 1000 Growth ETF (IWF) position steady in Q1 2026 at 2,572 shares worth $274K. The position accounts for 0.07% of the portfolio, ranked #98.

Boston Research & Management first reported a position in IWF in Q2 2021 and has held it in 16 quarters since. The position peaked at $310K in Q4 2024. 2,432 funds tracked by Wall St. Rank hold IWF as of Q1 2026.

  • Boston Research & Management held 2,572 shares of iShares Russell 1000 Growth ETF worth $274K as of Q1 2026.
  • Boston Research & Management left its iShares Russell 1000 Growth ETF share count unchanged in Q1 2026.
  • iShares Russell 1000 Growth ETF made up 0.07% of Boston Research & Management's portfolio in Q1 2026, its #98 holding.
  • Boston Research & Management first reported a position in iShares Russell 1000 Growth ETF in Q2 2021 and has held it in 16 quarters since.
  • Boston Research & Management's iShares Russell 1000 Growth ETF position peaked at $310K in Q4 2024.
  • 2,432 funds tracked by Wall St. Rank held iShares Russell 1000 Growth ETF as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.